SERA News and Press, Sera Prognostics Inc. From 06/08/23

2023-06-08 18:58:38 ET Summary Sera Prognostics is a promising company with a mission to improve pregnancy outcomes through its blood test product, PreTRM, which identifies biomarkers linked to premature birth. Premature birth is a significant issue, with 1 in 10 babies born prema...

Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue PR Newswire Aligning Management Team given New Refined Commercial Focus on Institutions Starting with Recent Appointment of Board Mem...

2023-05-15 17:53:03 ET Sera Prognostics ( NASDAQ: SERA ) announced on Monday the retirement of its president and CEO, Gregory Critchfield. Critchfield plans to step down from his executive role effective June 8. Zhenya Lindgardt will succeed Critchfield as interi...

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO PR Newswire SALT LAKE CITY , May 15, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASD...

2023-05-12 16:44:04 ET Sera Prognostics, Inc. (SERA) Q1 2023 Earnings Conference Call May 10, 2023 05:00 PM ET Company Participants Peter DeNardo - CapComm Partners, IR Greg Critchfield - Chairman, President & Chief Executive Officer Jay Moyes - Chief Financi...

2023-05-10 16:39:27 ET Sera Prognostics press release ( NASDAQ: SERA ): Q1 GAAP EPS of -$0.34 beats by $0.01 . Revenue of $0.1M (-73.7% Y/Y) in-line. Shares -0.73% . For further details see: Sera Prognostics GAAP EPS of -$0.34 beats by $0.01, revenue ...

SERA PROGNOSTICS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS PR Newswire SALT LAKE CITY , May 10, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing ...

Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2023 Financial Results on May 10, 2023 PR Newswire SALT LAKE CITY , April 27, 2023 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company ® (NASDAQ: SERA), ...

2023-03-28 06:16:32 ET Summary Sera Prognostics sells PreTRM, a CLIA-lab-based assay to determine the risk of a woman having a preterm birth - a birth prior to 37 weeks of gestation. Having gone public in an IPO in July 2021 at $16, the Company was trading below $1.30 prior to rel...

2023-03-22 20:56:07 ET Sera Prognostics, Inc. (SERA) Q4 2022 Earnings Conference Call March 22, 2023 5:00 PM ET Company Participants Peter DeNardo - CapComm Partners, IR Greg Critchfield - President and CEO Jay Moyes - CFO Conference Call Participants ...